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William C. Stoffregen,3 Evelyn A. Dean-Nystrom,3 Georg Baljer,1 and Christian Menge1*
Institut für Hygiene und Infektionskrankheiten der Tiere,1 and Institut für Virologie,2 Justus-Liebig-Universität, D-35392 Giessen,
Germany, and Pre-Harvest Food Safety and Enteric Diseases Research, National Animal Disease Center, USDA,
Agriculture Research Service, Ames, Iowa 500103
Received 6 May 2008/Returned for modification 19 June 2008/Accepted 26 August 2008
Bovine colonic crypt cells express CD77 molecules that potentially act as receptors for Shiga toxins
(Stx). The implication of this finding for the intestinal colonization of cattle by human pathogenic
Stx-producing Escherichia coli (STEC) remains undefined. We used flow cytometric and real-time PCR
analyses of primary cultures of colonic crypt cells to evaluate cell viability, CD77 expression, and gene
transcription in the presence and absence of purified Stx1. A subset of cultured epithelial cells had Stx
receptors which were located mainly intracellularly, with a perinuclear distribution, and were resistant to
Stx1-induced apoptosis and Stx1 effects on chemokine expression patterns. In contrast, a population of
vimentin-positive cells, i.e., mesenchymal/nonepithelial cells that had high numbers of Stx receptors on
their surface, was depleted from the cultures by Stx1. In situ, CD77 cells were located in the lamina
propria of the bovine colon by using immunofluorescence staining. A newly established vimentin-positive
crypt cell line with high CD77 expression resisted the cytolethal effect of Stx1 but responded to Stx1 with
a significant increase in interleukin-8 (IL-8), GRO-, MCP-1, and RANTES mRNA. Combined stimula-
tion with lipopolysaccharide and Stx1 increased IL-10 mRNA. Our results show that bovine colonic crypt
cells of epithelial origin are resistant to both the cytotoxic and modulatory effects of Stx1. In contrast,
some mucosal mesenchymal cells, preliminarily characterized as mucosal macrophages, are Stx1-respon-
sive cells that may participate in the interaction of STEC with the bovine intestinal mucosa.
Some Shiga toxin-producing Escherichia coli (STEC) strains,
enterohemorrhagic E. coli strains, are food-borne pathogens
which evoke life-threatening diseases in humans (26). Cattle
and other ruminants can shed STEC for long periods and are
a major reservoir for zoonotic STEC (6, 61, 70, 72). Emerging
human STEC infections make the reduction of STEC shedding
by reservoir species a current challenge in veterinary public
health.
Several lines of evidence indicate that STEC adherence to
bovine intestinal epithelial cells is essential for long-term
STEC colonization of ruminants. Within hours after oral in-
fection, STEC O157:H7 can be detected throughout the gas-
trointestinal tract, including the rumen, of cattle (6, 18). As
early as 4 days after inoculation, STEC strains colonize epi-
thelial cells in the ileum, cecum, colon, rectum, and gall blad-
der in weaned calves (8, 59, 62). STEC O157:H7 strains prin-
cipally colonize the rectoanal junction of weaned calves and
older cattle (10, 33, 44), but O157:H7 colonization also can
occur at other sites of the bovine intestinal tract (8, 23, 55). The
ability of the majority of bovine STEC isolates to intimately
attach to cells and rearrange the actin cytoskeleton (attaching-
and-effacing [AE] lesions) (71) may facilitate adherence to the
intestinal epithelium (5, 9, 44). Signature-tagged mutagenesis
studies showed that factors not involved in AE lesion forma-
tion further support STEC colonization of the bovine intestinal
epithelium (11, 68). The duration of STEC shedding correlates
with epithelial cell turnover in the bovine intestine (35). Vac-
cination strategies directed against proteins involved in STEC
adherence to the bovine intestinal mucosa have been suc-
cessful in reducing STEC O157:H7 infection in cattle (49,
50, 52, 67).
Other STEC factors also may influence the duration of col-
onization. Recent studies suggest that STEC suppresses the
bovine host’s immune response, limits mucosal inflammation,
and maintains intestinal homeostasis. Lymphostatin (2) and
Shiga toxin 1 (Stx1) (39) block the proliferation of bovine
lymphocytes in vitro. Stx1 alters the cytokine response of bo-
vine intraepithelial lymphocytes (42), cells that are scattered
within the epithelial layer and are affected in vivo by Stx1 from
STEC strains that do not colonize next to organized lymphoid
tissues (38). Some STEC O157:H7 strains exhibit a tropism for
the follicle-associated epithelium of Peyer’s patches in the bo-
vine intestine (51) and may release modulating factors adja-
cent to induction sites of the immune response. Development
of a cellular immune response against STEC antigens is sig-
nificantly delayed in calves inoculated with Stx2-producing E.
coli O157:H7 compared to that of calves inoculated with a
nontoxigenic O157:H7 strain (22). Immune-modulating STEC
factors are potential targets for future strategies aimed at re-
ducing STEC shedding in cattle, but their mode of action in the
bovine intestine is only partially understood.
Stx proteins are potent 1A:5B-structured cytotoxins with
RNA N-glycosidase activity that inhibit protein synthesis of
sensitive cells (13). Independent of cytolethal effects, Stx-in-
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duced expression of chemokines in human intestinal epithelial
cells (66, 74) may be a key event in the pathogenesis of human
STEC-related diseases (47). There is conflicting evidence
about whether Stx are involved in STEC-epithelial cell inter-
actions in cattle. Pruimboom-Brees et al. (54) did not detect
Stx receptors in the bovine intestinal epithelium, but other
researchers described the presence of Gb3/CD77 (a glyco-
sphingolipid Stx receptor found on sensitive cells) and Stx
binding sites in the bovine intestinal mucosa (20, 21, 57). Stx
receptor expression was ascribed to proliferating epithelial
cells at the bases of the crypts (21). However, Stx1 binding to
these receptors in vitro is not cytolethal but leads to a rapid
degradation of the toxin in the cellular lysosomal compartment
(21). We hypothesized that bovine colonic epithelial cells are
resistant to the cytotoxic, but not the modulatory, effects of
Stx1. We used flow cytometry, fluorescence microscopy, and
mRNA quantitation by real-time PCR to analyze Stx receptor
distribution and the effects of Stx1 in a colonic crypt cell cul-
ture system.
MATERIALS AND METHODS
Collection of bovine tissues. Intestinal specimens for the isolation of bovine
colonic crypts were obtained from freshly slaughtered cattle (18 to 24 months
old) of different breeds from a local abattoir (Giessen, Germany). Frozen bovine
distal colon tissues were available from earlier infection studies at the National
Animal Disease Center in Ames, IA, for the detection of CD14 and CD77 by
immunofluorescence. These last tissue specimens had been collected from
4-month-old weaned calves at necropsy, snap-frozen in isopentane, and stored at
80°C. Because STEC pathogenicity for cattle is restricted to the immediate
neonatal phase (7, 8, 10, 62), we considered both 4-month-old and older cattle
representative of cattle prone to asymptomatic STEC colonization.
Isolation of bovine colonic crypts. Crypts were isolated according to Föllmann
et al. (15), with some modifications. Tissue samples, consisting of approximately
30-cm-long sections from the ascending colon of each animal, were extensively
washed with isotonic NaCl solution (4°C) and cut open longitudinally. Mucus was
removed by slightly scraping tissue with a glass slide. Specimens were transported
to the laboratory in phosphate-buffered saline (PBS) supplemented with 100
U/ml penicillin, 100 g/ml streptomycin, 2.5 g/ml amphotericin, 4 mM L-glu-
tamine (PAA Laboratories GmbH, Pasching, Austria), 2.5 g/ml gentamicin
(Biochrom AG, Berlin, Germany), and 0.2% glucose (Merck, Darmstadt, Ger-
many). Mucosal tissue was separated from the lamina propria by scraping with a
sterile glass slide, homogenized by a razor blade in Hank’s buffered saline
solution (HBSS; 4°C) and transferred to 50-ml tubes (Greiner, Frickenhausen,
Germany). After centrifugation (5 min, 130  g, 4°C) the mucus-containing layer
was withdrawn together with the supernatant and discarded. The remaining
pellet was washed twice and enzymatically digested in 60 ml of Dulbecco’s
modified Eagle’s medium (DMEM; Invitrogen, Karlsruhe, Germany) plus 60 ml
of HBSS, 150 U/ml collagenase I (Biochrom), 2 mM L-glutamine, 100 U/ml
penicillin, 100 g/ml streptomycin, 2.5 g/ml gentamicin, and 2.5 g/ml ampho-
tericin. After incubation (45 min, 37°C, 8% CO2) with stirring (100 rpm), the
solution was passed twice through 0.6-by-25-mm needles to further disintegrate
cell clots. After a second digestion step (10 min) and subsequent centrifugation
(7 min, 202  g, 4°C), the remaining pellet was resuspended in a 2% D-sorbitol
solution (in HBSS) and centrifuged (5 min, 50  g, 4°C). The pellet was resus-
pended in 2% D-sorbitol. The procedure was repeated several times until the
supernatant was clear. The isolated crypts (the pellet) were washed with HBSS
(3 min, 65  g, 4°C) and resuspended in DMEM.
Primary bovine colonic crypt cell cultures. Crypts were seeded at a density of
350 to 400 crypts/cm2 (microscopic counts; 200 to 300 cells per crypt) in 25-cm2
culture flasks (Costar, Bethesda, United Kingdom) coated with rat tail collagen
(2.8 l/cm2 [CollagenR; Serva, Heidelberg, Germany], 1:10 in distilled water)
and cultivated (37°C, 8% CO2). Crypt culture medium consisted of DMEM
supplemented with 100 U/ml penicillin, 100 g/ml streptomycin, 2.5 g/ml gen-
tamicin, 2.5 g/ml amphotericin, 5 g/ml bovine transferrin (Invitrogen), 10
g/ml bovine insulin (Biochrom), 0.15 mM nonessential amino acids (Bio-
chrom), 1 g/ml hydrocortisone (Sigma-Aldrich, Steinheim, Germany), 30 ng/ml
epidermal growth factor (AF Schützdeller GmbH, Germany), 4 mM L-glutamine,
and 2.7 mg/ml glucose (Sigma-Aldrich). For the first 24 h, 10% fetal calf serum
(FCS; Invitrogen) was added. Further cultivation was performed in medium
containing the supplements named above with FCS at 2% only and an addition
of 0.5% bovine pituitary extract (C.C.Pro GmbH, Neustadt, Germany). In some
experiments, cells were cultured for 48 to 72 h in medium additionally supple-
mented with lipopolysaccharide (LPS) from E. coli O111:B4 (25 g/ml; Sigma-
Aldrich) or sodium butyrate (2 mM or 4 mM; Sigma-Aldrich). Flow cytometry
analysis of cells harvested from representative cultures (n  16) 96 h after
seeding of the crypts showed that the cultures consisted of 93.82%  2.61%
(mean  standard deviation) cytokeratin-positive (i.e., epithelial) and 6.07% 
4.16% vimentin-positive (mesenchymal) cells. These cultures are referred to as
primary colonic crypt cell cultures.
Generation and cultivation of bovine colonic crypt mesenchymal cell lines.
Primary bovine colonic crypt cells grown for 96 h in collagen-coated petri dishes
(diameter, 3.5 cm; Falcon), were lipofected with the pSV3neo plasmid carrying
the SV40 large-T antigen (48). Four micrograms of plasmid and 20 l of Super-
fect transfection reagent (Qiagen, Hilden, Germany) were mixed in 100 l of
DMEM, incubated for 10 min at 25°C and added to 1 ml of DMEM in each dish.
After incubation (3 h, 37°C), supernatants were withdrawn, and cells were cov-
ered with 5 ml of fresh medium. After 48 h at 37°C, the selection of transformed
cells was started by adding 40 l of Geneticin solution (50 mg/ml; Sigma-
Aldrich). Medium was changed every 48 to 72 h. When clonal proliferation
became visible, cells were detached by trypsin (0.25% in HEPES buffer supple-
mented with 0.2% EDTA; PAA), seeded into fresh cell culture flasks (Falcon),
and further propagated with RPMI 1640 medium containing 2 mM stabilized
L-glutamine and 2.0 mg/ml NaHCO3 (PAN Biotech GmbH, Aidenbach, Ger-
many), 100 U/ml penicillin, 100 g/ml streptomycin, and 10% FCS.
Cytotoxicity assays. The effect of Stx1 on the cellular metabolic activity was
quantified by MTT (3-[4,5-dimethyl-2-thiazolyl]-2,5-diphenyl tetrazolium bro-
mide, Sigma) reduction assay as described previously (39). Cells (2  104 per
well) were seeded into microtiter plates and incubated (72 h, 37°C) with purified
Stx1 (0.0002 to 2,000 CD50/ml; CD50 [50% cytotoxic dose] as determined on
Vero cells, where 1 CD50 was calculated to be equivalent to 0.4 to 0.8 pg/ml of
purified Stx1 [46]) without or after preincubation with purified mouse anti-StxB1
(immunoglobulin G1 [IgG1], clone 13C4; 1.5 g/ml [63]). Methods for Stx1 and
anti-Stx1 subunit B (StxB1) purification were previously published (39). Epithe-
lial cell-specific apoptosis was quantified using an M30 CytoDEATH fluorescein
isothiocyanate (FITC) test kit (Roche, Mannheim, Germany) and flow cytometry
analysis.
Flow cytometry. There is no indication that trypsin cleaves the Stx receptor
Gb3/CD77, a glycosphingolipid, or that trypsin cleavage of proteinaceous Gb3/
CD77 ligands on the surface of bovine cells unmasks Stx receptors and makes
them more accessible for toxin binding. The only physiological Gb3/CD77 ligand
detected so far in cattle is the type I interferon receptor protein (IFNAR) (17).
However, the affinity of Stx1 for Gb3/CD77 is greater than the affinity of IFNAR
for Gb3/CD77 (27). Thus, the use of trypsin was considered appropriate to
generate cell suspensions for flow cytometry analysis of StxB1 binding to bovine
colonic cells. Cells were detached by trypsinization, transferred to V-shaped
microtiter plates (Greiner), and pelletized by centrifugation (150  g, 7 min,
4°C). Detection of cell surface antigens and surface binding sites for the recom-
binant StxB1 (rStxB1) was performed with native cells as described previously
(37, 60). Leukocyte antigens were detected using antibodies listed in Table 1.
Binding of rStxB1 was detected by subsequent incubation with purified rStxB1
(30 g/ml PBS [60]), anti-StxB1 clone 13C4 (45 g/ml PBS), and anti-mouse
IgG() FITC (Medac, Hamburg, Germany). For detection of intracellular anti-
gens, cells were fixed in paraformaldehyde (2% in PBS; 30 min, 25°C), washed
with PBS, and permeabilized with digitonin (0.005% in PBS, 10 min, 25°C
[Sigma-Aldrich]). Subsequently, cells were incubated with FITC-conjugated anti-
pan cytokeratin antibody (clone C-11, 1:100 in PBS [Sigma-Aldrich]) or anti-
vimentin antibody (clone 3B4, 1:13 in PBS [Dako, Hamburg, Germany]) and
phycoerythrin-conjugated anti-mouse IgG antibody (1:50 in PBS [Sigma-Al-
drich]). Finally, cells were washed twice and analyzed on an Epics Elite analyzer
(Beckman-Coulter, Krefeld, Germany), acquiring 5,000 events per sample. Data
were analyzed with FCS Express version 2 software (DeNovo software, Thorn-
hill, Canada). Gates were defined according to the negative control (PBS) and
secondary antibody control included in each test series, defining less than 2% of
the cells as positive.
Immunofluorescence staining for microscopy. Cells grown in 12-well culture
plates (Costar) were fixed and permeabilized as described for flow cytometry but
omitting trypsinization. While being washed in PBS, the floors of the wells were
punched out using a heated copper cutter and placed in PBS-prefilled 12-well
plates for further processing. Labeling was carried out as described above, and
samples were mounted on glass slides and dried overnight at 4°C. Immunoflu-
orescence microscopy was performed using a Leica DMRB Laborlux 12 micro-
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scope with an analog camera (for conventional fluorescence microscopy) or a
Leica DM IRBE microscope (for confocal fluorescence microscopy).
For immunofluorescence detection of CD14- and CD77-positive cells in situ,
5- to 6-m sections of isopentane-flash-frozen bovine colon tissues were cut,
fixed in cold ethanol (20°C) for 10 s, and stored at 80°C until used. Slides
were removed from 80°C storage and set directly 6 inches under a fluorescent
light source for 18 to 20 h to quench nonspecific fluorescence, rehydrated (0.023
M PBS [pH 7.4], 30 min), and incubated in diaminobenzidine solution (Histo-
Mark kit; Kirkegaard & Perry Laboratories, Gaithersburg, MD) for 10 min to
block naturally fluorescent eosinophils (28). Sections were incubated for 30 min
at room temperature with Image iT FX signal enhancer (Molecular Probes,
Eugene, OR), washed with PBS with 0.125% Tween 20 (PBS-T), incubated for
18 h at 4°C with combined rat anti-human CD77 IgM (clone 38.13, 1:20 in PBS-T
[Serotec, Raleigh, NC]) and mouse anti-M-M9 (CD14) IgG1 (clone CAM36A,
1:200 [VMRD, Pullman, WA]), washed in PBS-T, and incubated for 30 min
(25°C) with Alexa Fluor 594-labeled goat anti-rat IgM and Alexa Fluor 488-
labeled goat anti-mouse IgG1 ([Molecular Probes] 1:800 in PBS-T with 5%
normal goat serum [Vector Laboratories, Burlingame, CA]). Rat IgM isotype
control (1:20 [Cedarlane, Burlington, NC]) and mouse IgG1, clone W3/25, iso-
type control (1:500 [Serotec]) were used as negative control sera. Slides were
examined by fluorescence microscopy (Nikon E800 microscope). Images were
acquired using a digital camera (Spot) and MetaVue software.
Quantitation of mRNA species. Primary colonic crypt epithelial cells grown to
confluence in collagen-coated cell culture flasks within 96 h after seeding or
confluent immortalized colonic crypt mesenchymal cells 48 h after passaging
were incubated for 4 and 24 h (37°C) with purified Stx1 (200 CD50/ml). For
comparison, cells were cultured with Stx1 after preincubation (30 min) with
purified mouse anti-StxB1 (1.5 g/ml). Cells were detached by trypsinization and
washed twice (202  g, 7 min, 20°C) with PBS. Cells were counted, and 1  106
cells were lysed in 600 l of RLT buffer (RNeasy mini-kit; Qiagen, Hilden,
Germany) with 2.5% -mercaptoethanol (Amersham Biosciences, Buckingham-
shire, United Kingdom) and stored at 70°C. The RNA isolation procedure and
reverse transcription were performed according to the method described by
Moussay et al. (42). PCR amplification was done on an automated fluorometer
(ABI PRISM 5700 sequence detection system; Applied Biosystems) using 96-
well optical plates. Sequences of primers and probes used to detect mRNA for
the interleukin-8 (IL-8), GRO-	, MCP-1, RANTES, and TGF- proteins have
been published previously (31, 42).
Granulocyte migration assays. A modification of the method described by
Galligan and Coomber (16) was used as published (42). In brief, bovine granu-
locytes were obtained by density gradient centrifugation and lysis of erythrocytes.
After bovine colonic crypt cells were cultured for 4 and 24 h in the absence or
presence, respectively, of Stx1, supernatants (agonists) were obtained by centrif-
ugation at 10,000  g for 10 min and transferred into 12-well plates (i.e., the
lower compartment of the migration chamber). The upper compartments of all
migration chambers (12-mm Transwell clear culture inserts, 3-m pores; Corn-
ing Costar, Germany) were placed in the wells, and each was filled with medium
containing 5  105 granulocytes. After a 2-h incubation at 37°C, granulocytes
from both compartments were harvested and counted by flow cytometry using
3-3
dioctadecyloxacarbocyanine perchlorate (DiO)-labeled BL-3 cells (ECACC
catalog code 86062401) as counting particles. Spontaneous granulocyte migra-
tion, i.e., migration of granulocytes in chambers in which the lower compartment
was filled with nonconditioned medium (freshly prepared medium not having
been in contact with cells), was used as a reference (i.e., 100%).
Statistical analysis. Data were analyzed by Student’s t test and two-way
analysis of variance (ANOVA) for normal distributed data and by the Mann-
Whitney rank sum test for nonnormal distributed data (SigmaStat software,
versions 2.03 and 3.11; SPSS Inc.). In all analyses, a significance level, 	, of
0.05 was applied; levels of probability are indicated in the legends to the
figures. Results were considered not significant if P was more than 0.05 and
omitted from the figures.
RESULTS
Stx receptor expression by primary colonic crypt epithelial
cells. Flow cytometry analysis revealed that 5.3%  0.56%
(n  16 determinations/four independent experiments) of na-
tive bovine colonic crypt cells obtained from cattle, analyzed
96 h after crypts were seeded, expressed CD77 on the cell
surface. After permeabilization, which allowed the antibody to
access the interior of the cells, CD77 became detectable in
16%  10.8% of the cells (n  24/eight experiments). The
portion of cells that bound rStxB1 upon permeabilization was
22.5%  17.9%. The majority of CD77 or rStxB1-positive
cells within the cultures were not cytokeratin-positive cells.
Analysis of double-labeled cells was complicated by a signifi-
cant variation in cellular autofluorescence, but, according to
gates set relative to that of the control samples prepared with-
out primary reagents, only a minor portion of CD77 and
rStxB1-binding cells could be assigned to the cytokeratin-pos-
itive epithelial cell population (Fig. 1).




Host Isotype Label Clone Sourcea
CD11a Mouse IgG2a IL-A99 DW Nondiluted
CD11b Mouse IgG1 IL-A15 JN Nondiluted
CD11c Mouse IgG1 IL-A16 JN Nondiluted
CD14 Mouse IgG1 CC-G33 DW Nondiluted
CD21 Mouse IgG2a IL-A65 JN Nondiluted
CD25 Mouse IgG1 IL-A111 JN Nondiluted
CD71 Mouse IgM IL-A77 JN Nondiluted
CD77 Rat IgM 38.13 Beckman-Coulter 1:10 in PBS
CD80 Mouse IgG1 IL-A190 DW Nondiluted
CD86 Mouse IgG1 IL-A158 DW Nondiluted
CD172a Mouse IgG1 IL-A24 JN Nondiluted
MHC-I Mouse IgG2a IL-A88 JN Nondiluted
MHC-II DQ Mouse IgG2a CC158 DW Nondiluted
MHC-II DR Mouse IgG1 CC108 DW Nondiluted
ACT-2 Mouse IgG1 CACT26A VMRD Inc. 1:400 in PBS
Vimentin Mouse IgG1 3B4 Dako A/S 1:13 in PBS
Pan-cytokeratin Mouse IgG1 FITC C-11 Sigma-Aldrich 1:100 in PBS
Mouse IgG() FITC Medac 1:200 in PBS
Mouse IgG Phycoerythrin Sigma-Aldrich 1:50 in PBS
Rat IgM() Phycoerythrin Beckman-Coulter 1:200 in PBS
Rat IgM FITC Dianova 1:100 in PBS
a DW, Dirk Werling, Royal Veterinary College London, United Kingdom; JN, Jan Naessens, International Livestock Research Institute, Nairobi, Kenya.
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Immunofluorescence microscopy analysis was used to iden-
tify cells of epithelial origin in colonic crypt cultures. Epithelial
cells were identified by anti-cytokeratin immunostaining after
fixation and permeabilization (Fig. 2A). A subset representing
approximately 15% of these large, mono- or binucleated cells
stained weakly with anti-CD77. The signal was distributed in a
spot-like manner within the cellular body surrounding the nu-
cleus. A similar perinuclear signal distribution was observed in
binding studies with purified rStxB1 (Fig. 2B). Neither CD77
nor rStxB1 binding sites were detected on the surface of co-
FIG. 1. Detection of CD77 antigens (A) and binding sites for rStxB1 (B) in primary bovine colonic crypt epithelial cells. Monolayers of cells
grown from seeded colonic crypts within 96 h of culture were detached by trypsinization, fixed, permeabilized, and incubated with anti-CD77 and
rStxB1, respectively. Flow cytometry analysis of the cells with gates set relative to control samples without primary reagents revealed that anti-CD77
and rStxB1 bound to a small portion of cytokeratin-positive cells. Dot plots are representative of 12 determinations from five independent
experiments. Percentages of positive cells are shown in the upper right corner of the plots. PE, phycoerythrin.
FIG. 2. Localization of CD77 antigens and binding sites for rStxB1 in primary bovine colonic crypt epithelial and mesenchymal cells.
Monolayers of cells grown from seeded colonic crypts within 96 to 120 h of culture were fixed, permeabilized, and overlaid with anti-CD77 and
rStxB1, respectively. By using conventional fluorescence microscopy, we detected CD77 in epithelial cells (cytokeratin-positive) in a spot-like
distribution surrounding the nucleus (A, arrowheads). Epithelial cells also harbored perinuclear rStxB1 binding sites (B, arrowheads). (C) A small
population of cytokeratin-negative cells strongly bound anti-CD77 (arrows). (D) Double labeling with anti-vimentin revealed that the latter cells
(arrows) were of mesenchymal origin (i.e., vimentin-positive), while cells with a perinuclear CD77 localization were vimentin-negative (arrow-
heads). Figures depict labeled cells from selected regions and are not representative of all cells in culture. Original magnification was 400.
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lonic crypt epithelial cells by conventional fluorescence micros-
copy or by confocal laser scanning microscopy (data not
shown).
Supplementation of cell culture medium with LPS (25 g/
ml) or different concentrations of sodium butyrate (2 to 4
mM), the latter of which is known as a transcriptional regulator
of differentiation genes in many cell types, did not significantly
affect the percentage of CD77 cells in colonic crypt cell cul-
tures (25.9%  8.8%, 28%  8.8%, 23.7%  5.7%, and
24.3%  6.7% in the medium control and after cultivation with
LPS, 2 mM butyrate, and 4 mM butyrate, respectively; n  4
independent experiments; P  0.05, Student’s t test) as deter-
mined by flow cytometry analysis.
Functional analysis of primary colonic crypt cells cultured
in the presence of Stx1. Colonic crypt cells were passaged and
plated with purified Stx1 (0.0002 to 2,000 CD50/ml, quantified
on Vero cells). After further incubation for 72 h, the cellular
metabolic activity of Stx-treated cells (determined with an
MTT reduction assay) was not different from that of control
cultures (P  0.05 for the impact of Stx1 concentration; two-
way ANOVA). Stx1 with or without costimulation by LPS had
no significant effect on epithelial cell-specific apoptosis (by
M30 CytoDEATH test; data not shown).
Stx1 did not significantly alter the amount of mRNA for
IL-8, GRO-	, MCP-1, RANTES, and the epithelial cell differ-
entiation factor TGF- (Fig. 3A). Extending the incubation
time to 24 h did not result in Stx1 having a significant effect on
the quantities of specific mRNA (data not shown). Stx1 also
did not alter the release of granulocyte chemoattractants:
within 24 h, colonic crypt cells released detectable amounts of
granulocyte migration-inducing substances into the culture su-
pernatant, but the quantities did not differ between those of
Stx1-treated and nontreated cultures (Fig. 3B).
Identification of CD77 mesenchymal cells in the bovine
colonic mucosa. Conventional fluorescence microscopy and
confocal laser scanning microscopy examination of colonic
crypt cell cultures obtained from 18- to 24-month-old cattle
revealed the presence of a small population of cells (approxi-
mately 5% of the monolayer) that intensely expressed CD77
(Fig. 2CD) and rStxB1 binding sites (data not shown) on the
cell surface. The cells were cytokeratin negative (Fig. 2C) but
vimentin positive (Fig. 2D). Flow cytometry analyses showed
that these cells were Stx1 sensitive (i.e., supplementation of the
culture medium with Stx1 led to a reduction in the number of
CD77 and vimentin-positive but cytokeratin-negative cells;
data not shown).
Immunohistologic staining of frozen tissues from 4-month-
old calves was used to confirm the presence of CD77 cells of
mesenchymal origin in the bovine colon in situ. An infrequent
presence of CD77 cells was found in subbasilar lymphoid
aggregates within the lamina propria, and occasionally, scat-
tered individual CD77 cells were found in the lamina propria
not associated with lymphoid aggregates. Smooth myocytes
within the tunica muscularis were occasionally CD77. Immu-
nohistologic staining identified the frequent CD14 cells
within the epithelium of mucosal crypts, as well as the surface
epithelium. Individual CD14 cells were found within the lam-
ina propria, particularly focused in lymphoid aggregates.
CD14 cells were also found within the connective tissue be-
tween smooth muscle bundles in the tunica muscularis. Cells
staining positive with both anti-CD77 and anti-CD14 were not
seen in the epithelium of the mucosal crypts or surface epithe-
lium but were detected in low numbers in the lamina propria
between the colonic crypts (Fig. 4).
Generation and characterization of colonic crypt mesenchy-
mal cell lines. We established and evaluated 10 vimentin-pos-
itive cell clones from bovine colonic crypt cell cultures that
were used to identify and characterize colonic crypt mesenchy-
FIG. 3. Relative quantities of gene transcripts harbored by bovine
colonic crypt cells upon cultivation in the presence of purified Stx1
(A) and migratory activity of bovine granulocytes toward supernatants
derived from these cultures (B). Cells grown from seeded colonic
crypts within 96 h were further incubated for 4 h with Stx1 (200
CD50/ml, as determined on Vero cells) without or after preincubation
with anti-StxB1 (1.5 g/ml) (A). Subsequently, mRNA was reverse
transcribed and quantified by real-time PCR. Transcription of the
GAPDH housekeeping gene was used for normalization of the sam-
ples. Cells incubated with medium were used as a control (i.e., 100%;
indicated by the horizontal line). Data are the mean values of six
independent experiments; minima and maxima are indicated by aster-
isks at the end of the vertical lines. Analysis by the Mann-Whitney rank
sum test did not detect any statistically significant effect of Stx1. The
release of granulocyte chemoattractants in these cultures was deter-
mined with a filter-based migration assay (B). Bovine granulocytes
were allowed to migrate for 2 h at 37°C toward the lower compart-
ment containing the agonists: supernatants of untreated colonic
crypt cell cultures (i.e., medium only), supernatants of cultures
incubated with Stx1 without (Stx1) or after preincubation with
anti-StxB1 ( Stx1 anti-StxB1). Granulocytes were then harvested
and counted. Results are expressed relative to the spontaneous
granulocyte migration occurring in chambers, in which the lower
compartment was filled with nonconditioned (i.e., fresh) medium
(100%). Data are means and standard deviations of five to six
independent migration assays with supernatants of colonic crypt cell
cultures conditioned for 4 and 24 h.
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mal cells that are potentially sensitive to Stx1. Cells of all
clones stained positive with anti-CD77 after permeabilization.
Nonpermeabilized cells of one line (designated clone 12) ex-
hibited a marked CD77 expression on the cell surface (Fig. 5A
and B) and coexpressed major histocompatibility complex class
I (MHC-I), CD14, and CD172a (Fig. 5B) but lacked MHC-II
DQ, MHC-II DR, CD11a, CD11b, CD11c, CD21, CD25,
CD71, CD80, CD86, and ACT-2 (data not shown).
Effects of Stx1 on immortalized colonic crypt mesenchymal
cells. Incubation of clone 12 cells with 200 verocytotoxic CD50
of Stx1/ml did not alter the cellular metabolic activity in com-
parison to that of cells cultured with Stx1 plus anti-StxB1 (P 
0.05 for the impact of Stx1 concentration; two-way ANOVA).
Despite this, Stx1 markedly lowered the percentage of cells
with CD77 on the cell surface (Fig. 6). Permeabilization of
cells from Stx1-treated and -nontreated cultures prior to label-
ing with anti-CD77 generally increased the numbers of CD77-
positive cells. This applied particularly to Stx1-treated cultures,
thereby markedly reducing the effect of Stx1 on the percentage
of CD77-positive cells. The findings are consistent with an
Stx1-induced redistribution of CD77 from the cell surface to
intracellular compartments. Supplementation of the medium
with LPS slightly reduced the percentage of CD77 cells with-
out influencing the effect of Stx1 on the surface versus intra-
cellular expression of CD77.
Addition of Stx and LPS to clone 12 cells significantly in-
creased the quantities of mRNA specific for IL-8, GRO-	,
MCP-1, RANTES, and IL-10 relative to that of the LPS con-
trol. Stx1 induced this effect within 4 h (data not shown), but
the effect was more prominent within 24 h (Fig. 7). Stx1, with
or without LPS, did not alter the quantities of TGF-- and
IL-12-specific mRNAs.
DISCUSSION
Epithelial cells are the first host cells exposed to Stx during
infections of cattle with STEC. Cells in the depths of bovine
colonic crypts express Stx receptors (20), but Stx are not en-
terotoxic in cattle (54) as they are in rabbits (25, 40). To
determine if epithelial cells in the bovine intestine are respon-
sive to Stx, we identified and characterized Stx receptor-ex-
pressing cells in bovine colonic crypt cultures. A small subset of
primary epithelial cells harbored Stx receptors, apparently with
a predominantly intracellular location. Epithelial cells resisted
the cytolethal effect of Stx1 and also did not respond to the
toxin by releasing immune mediators. Some cultured nonepi-
thelial cells also had Stx receptors, as did the nonepithelial cells
we localized adjacent to colonic crypts in situ. One subset of
Stx receptor-positive nonepithelial cells was preliminarily iden-
tified as mucosal macrophages and responded to low concen-
trations of Stx1 by altering their chemokine and cytokine ex-
pression patterns in vitro. Identification of cells with various
receptor expression patterns and Stx responsiveness will help
elucidate the roles of different types of colonic cells during
STEC colonization of the bovine intestine.
Using overlay assays of frozen sections of bovine intestinal
tissues, other investigators have detected binding of Stx1 or
anti-CD77 antibodies to the apical surface of cells in the crypt
region of the small and large intestines (20, 21, 57). Crypts are
composed of mixed populations of cells including immature
proliferating cells, a subset of which migrates out of the crypts
and differentiates, acquiring the enzymatic and morphological
characteristics of mature surface epithelium. It has been sug-
gested that the observed lack of Stx1 binding to surface epi-
thelium in the bovine colon corresponds to a loss of Stx recep-
tors as the cells differentiate (20). Hoey et al. (21) reported
that Stx1 did not bind to monolayers of colonic crypt cells in
vitro but that Stx receptors localized specifically to the remain-
ing crypt fragments, which consisted of cells expressing prolif-
eration markers but were not further specified by the authors.
We did not assess the proliferation rate of the cells analyzed
herein. Advanced functional analyses (P. S. Bridger, M. Mohr,
I. Stamm, J. Fröhlich, S. Birkner, W. Föllmann, H. Metcalfe,
D. Werling, G. Baljer, and C. Menge, unpublished data) re-
vealed that cells with epithelial cell morphology retained their
ability to polarize, as indicated by the expression of tight junc-
tion marker ZO-1 when grown on collagenized 3-m-pore
filters. Low lactase and sucrase enzymatic activities of colonic
crypt cultures, as used for this study, are evidence that these
cells were immature and representative of epithelial cells in the
bovine colonic crypts. By using flow cytometry analysis, we
detected a small number of cytokeratin-positive cultured co-
lonic epithelial cells that coexpressed CD77 and bound rStxB1.
Using conventional and confocal microscopy, however, we did
not find CD77 and rStxB1 binding sites, either on the surface
of primary bovine colonic epithelial cell monolayers or associ-
ated with crypt fragments that had remained in the cultures. A
weak reaction with anti-CD77 was restricted to intracellular
sites and a subset of epithelial cells. It has been speculated that
some human leukocytes harbor Stx receptors that are different
from those of CD77 (64), but this does not appear to be the
case with bovine colonic cells. Although the antibody against
CD77 used in our study does not recognize all isoforms of
FIG. 4. Immunodetection of CD14- and CD77-expressing cells in
the bovine colonic mucosa. Frozen sections of distal colon tissue from
a 4-month-old calf were fixed and immunostained with antibodies
against CD14 (green) and CD77 (red). Nuclei were stained with 4
,6
-
diamidino-2-phenylindole (DAPI; blue). Fluorescence images were
captured in black and white and then pseudocolored (upper row of
images). Arrows in the lower merged image identify examples of the
colocalization of CD14 and CD77 in the lamina propria (LP) between
the colonic crypts (CR).
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Gb3/CD77 that may serve as Stx receptors (3), the similarities
between the anti-CD77 binding and cellular labeling patterns
and those of rStxB1 appear to rule out the existence of alter-
nate Stx binding sites on cultured bovine colonic epithelial
cells. The lack of detectable Stx receptors on the surface of
cultured epithelial cells also cannot be explained by a depen-
dency on a very early immature state or on polarization of the
cells, as anti-CD77-labeling patterns were similar to that of
polarized cells on filter inserts and cells grown on plastic sur-
faces (data not shown).
The lack of Stx receptors on the cell surface of cultured
epithelial cells was corroborated by the absence of significant
anti-CD77 staining in the epithelial layers of nonpermeabilized
bovine colonic tissues examined immunohistologically in this
study. Weak anti-CD77 staining of crypt mucosal epithelial
cells, similar to that shown for the cultured epithelial cells (Fig.
FIG. 5. Phenotype of bovine colonic crypt mesenchymal cell line clone 12. Conventional fluorescence microscopy of the immortalized cell line
upon permeabilization revealed an abundant CD77 expression with a spot-like pattern (A). Original magnification was 400. Flow cytometry
analysis (B) of native, nonpermeabilized cells revealed that CD77 expression on the cell surface was restricted to a major subpopulation of the cells
at the time of labeling, while virtually all cells expressed MHC-I, CD14, and CD172a. Dot plots are representative of double determinations from
one to three independent experiments. Percentages of positive cells are given in the upper right corners of the plots. PE, phycoerythrin.
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2), was noted in some samples but was interpreted as variable
background staining and was not characterized further. Previ-
ous discrepant findings about whether bovine epithelium ex-
presses Stx receptors (20, 54) have been attributed to method-
ological constraints (20). The method applied herein for
harvesting and processing tissue specimens from the bovine gut
best maintains the structure of the intestinal mucosa (32). The
clearly detectable binding of anti-CD77 to cells of the lamina
propria in this study confirms the suitability of this method.
The exact lineage assignment of crypt cells and the biochemical
character of the structure that allows Stx1, but not Stx2, to bind
to bovine crypts in tissue sections in some instances (57) have
not been determined.
The results of our study imply that the majority of Stx re-
ceptors on bovine colonic crypt epithelial cells are inaccessible
to luminal Stx. In experimentally and naturally infected cattle,
STEC organisms principally colonize absorptive cells of the
luminal epithelium in the bovine colon and not epithelial cells
in the depth of the crypts (7, 43). Stx is not enterotoxic in calves
(54), and epithelial lesions during bovine STEC infections can
be ascribed to the ability of the bacteria to cause AE lesions
(9). Our findings extend evidence that multiple factors contrib-
ute to the extensive resistance of intestinal epithelial cells to
the cytolethal effect of Stx in situ during STEC infections of
cattle. These factors may include low concentrations of Stx in
the crypts, a lack of bovine epithelial Stx2 receptors (57),
extensive absence of Stx1 receptors from the surface of crypt
epithelial cells (as in this study), and eventually a specific
endocytotic pathway possessed by the remaining cells that still
may endocytose some amounts of the toxin (21).
We did not detect a cytolethal effect of Stx on bovine colonic
epithelial cells, but it is possible that the cells respond to Stx by
other means. Granulocyte migration assays showed that incu-
bation of cultured bovine colonocytes with 200 verocytotoxic
CD50/ml Stx1 (equivalent to concentrations in the lower nano-
gram range [46, 57]) had no effect on the release of granulocyte
chemoattractants. Treatment also left the quantities of se-
lected chemokine mRNAs unaltered. In human intestinal ep-
ithelial cell lines, 10 ng/ml Stx1 increased the amount of IL-8
FIG. 6. Effect of Stx1 on CD77 expression by bovine colonic crypt mesenchymal cell line clone 12. Cells were incubated for 72 h with Stx1 (200
CD50/ml, as determined with Vero cells) without or after preincubation with anti-StxB1 (1.5 g/ml). CD77 was quantified by flow cytometry after
labeling of native cells (left) and of permeabilized cells (right). Student’s t test detected P  0.05 (*), P  0.01 (**), and P  0.001 (***).
FIG. 7. Effect of Stx1 on the relative quantities of gene transcripts
harbored by bovine colonic crypt cell line clone 12. Cells were incu-
bated for 24 h with Stx1 (200 CD50/ml, as determined with Vero cells)
without or after preincubation with anti-StxB1 (1.5 g/ml). Subse-
quently, mRNA was quantified as described in the legend to Fig. 3.
Data are the means of three independent experiments without (A) or
with (B) additional supplementation of the culture medium with LPS.
Minima and maxima are indicated by asterisks at the end of the vertical
lines. In the absence of LPS, the IL-10 and IL-12 mRNA was detect-
able only in one of three cultures. Student’s t test detected P  0.05
(*), P  0.01 (**), and P  0.001 (***). Bold asterisks above hori-
zontal brackets indicate significant differences between Stx1- and Stx1
 anti-StxB1-treated cultures.
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protein (65) and 1 ng/ml increased the amount of IL-8 mRNA
(74). Concentrations of Stx1 similar to those in the present
study induced a 40-fold increase in the amount of IL-4 mRNA
in bovine intraepithelial lymphocytes (42). We therefore inter-
pret our findings as sufficient evidence to conclude that bovine
colonic crypt epithelial cells are largely resistant to Stx also in
terms of conferring proinflammatory signals.
Surprisingly, we identified novel mesenchymal/nonepithelial
Stx target cells in the crypt area of the bovine colonic mucosa.
A subset of cytokeratin-negative, vimentin-positive cells with
fibroblast-like morphology in primary bovine colonic crypt cell
cultures intensely expressed CD77 on the surface and were
sensitive to modulation by Stx1. To our knowledge, this is the
first report of immunohistochemical identification of mesen-
chymal CD77 cells scattered within the colonic lamina pro-
pria of cattle. To evaluate the origin and the significance of
these Stx1 target cells, we generated several clones by the
immortalization of primary cells. One of these clones, desig-
nated clone 12, resembled mesenchymal cells in the primary
cultures as it expressed high levels of CD77 on the cell surface.
However, only a small subset of CD77 cells within the lamina
propria of the bovine distal colon coexpressed CD14, as did
clone 12. Thus, clone 12 is representative of only one of several
CD77 mesenchymal cell types in the bovine colonic mucosa
that are potentially sensitive to Stx in situ.
Several criteria led us to consider that clone 12 may have
descended from (i) fibroblasts, (ii) myofibroblasts, (iii) den-
dritic cells (DCs), or (iv) monocytes/macrophages. (i) Clone 12
cells have a spindle-shaped morphology resembling that of
fibroblasts. Tissue fibroblasts descend from the primary mes-
enchyme or may develop as blood-derived fibrocytes from
CD14 monocytes (1). Like clone 12 cells, blood-derived fi-
brocytes express CD172a, lack MHC-II expression (1), and
produce IL-10 (4). Unlike clone 12 cells, however, blood-de-
rived fibroblasts cease to express CD14 upon cultivation (1).
(ii) The spatial distribution of CD77 cells in the lamina pro-
pria of the bovine colon was comparable to the binding pat-
terns of Stx1 and Stx2 to pericryptic fibroblasts (synonymous
with myofibroblasts) in human intestinal tissue (57). Myofibro-
blasts are specialized fibroblasts that share phenotypical prop-
erties of fibroblasts and smooth muscle cells, are located di-
rectly below the epithelium (53), and have been implicated in
Stx-induced damage of the human colonic mucosa (57). (iii)
Clone 12 cells share similarities with DCs, including expression
of CD172a. Bovine CD172a is expressed principally by granu-
locytes, monocytes, macrophages, and a subpopulation of af-
ferent lymph veiled cells and by cells with DC morphology in
lymphoid tissues, skin, and intestinal epithelium (12, 19, 36).
Contact between mucosal DCs and epithelial cells induces the
expression of tight junction proteins, enabling the DCs to open
the epithelial cell junctions without affecting the integrity of
the monolayer and to extrude dendrites into the gut lumen
(56). Such intraepithelially located DCs may have been iso-
lated during the crypt preparation. (iv) Several lines of evi-
dence favor the notion that clone 12 cells descended from
macrophages. Werling et al. (69) observed that stimulation
with Toll-like receptor agonists (e.g., LPS) induces different
reaction patterns in bovine macrophages and DCs: while DCs
predominantly respond by transcribing IL-12, macrophages
typically respond with IL-10 transcription. Cells of clone 12
responded, independently of Stx1, to LPS stimulation with
increased IL-12 transcription (data not shown), implying their
relationship to DCs. However, clone 12 cells lacked CD11c, a
major marker for DCs (45), but expressed CD14, typical for
bovine macrophages (24). Resident macrophages are devoid of
CD14, but macrophages derived from blood monocytes are
CD14 (58). Macrophages experiencing LPS are characterized
by an IL-10high and IL-12low phenotype and support type II
immune responses (41). Morphological features, markers, and
cytokine expression profiles, and the fact that Stx1, in conjunc-
tion with LPS, induces a shift toward increased IL-10 transcrip-
tion, led us to propose that the predecessors of clone 12 cells
belong to type II intestinal macrophages.
Initial attempts to purify mesenchymal cells from the crypt
preparations resulted in heterogenous cultures of primary
cells, with variable CD172a expression, which were not suitable
for further functional analyses. Transfection with the pSVneo3
plasmid carrying the simian virus 40 (SV40) large-T antigen
under the control of the SV40 promoter allowed us to select
for cells originating from a single progenitor cell by limiting
dilution analysis. Since the level of Stx receptor expression
correlates with the state of malignant degeneration of cells,
data obtained with immortalized cells must be interpreted with
some caution. Normal human colonic epithelial cells lack
CD77, but the Stx receptor is highly expressed by metastatic
colon cancer (29). Normal bovine B cells resist the cytolethal
effect of the toxin (39), but bovine B cells transformed by
infection with a retrovirus (e.g., bovine leukemia virus) are
highly susceptible to the apoptosis-inducing effect of Stx1 (14,
39). Likewise, retroviral transfection of Madin-Darby canine
kidney cells with the human multidrug resistance efflux pump
(MDR1) increased expression of Stx receptors and cell sensi-
tivity to Stx1 (30). Though the authors of the last report discuss
the possibility that the retroviral infection per se has selected a
subpopulation of Stx-sensitive cells, the effect could be attrib-
uted mainly to the activity of the efflux pump. Clone 12 cells,
utilized as a tool in this study, closely resembled a subset of
primary cells in the initial bovine colonic crypt cultures with
regard to cellular distribution of CD77 and rStxB1 binding
sites and resisted the cytolethal effects of Stx1. The detection of
CD77 mesenchymal cells in bovine colonic crypt tissues in
situ (this study) together with the observation that primary
bovine monocytes coexpress CD172a and CD77 (C. Menge,
personal observation) strongly supports the conclusion that
CD77 expression is an inherent feature of the progenitor cell
of clone 12 and was not induced de novo by transfection with
retroviral genes.
Despite the fact that the progenitor cells of the different
mesenchymal/nonepithelial cells adjacent to bovine colonic
crypts are yet to be fully defined, the data presented here point
to the possibility that various Stx-responsive cells in the lamina
propria are involved in the interaction between STEC and the
bovine intestine. Intestinal antigen sampling cells have gained
considerable interest in recent years because of their implica-
tion in the induction of oral tolerance to commensal bacteria
(34, 73). Studying the interaction of STEC and bovine intesti-
nal lamina propria cells with and without Stx receptors may
help to elucidate how STEC realizes a commensal-like lifestyle
in cattle and facilitate the development of effective strategies
to reduce shedding of this zoonotic pathogen by ruminants.
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